Insider Trading › LH › Insiders
LABCORP HOLDINGS INC.
LH·NYSE·
United States·Insider activity
United States·Insider activity$311.97
+0.26 (+0.08%)
Close · Oct 7, 2026 · Close Prices from Tiingo.com
LH
Insider purchases and sales on the price
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
LHS&P 500 (rebased)
Insider BuyInsider SellForm 144 · planned sale
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
In the last 180 days, LH insiders filed 0 purchases ($0) and 9 sales ($5.0M) on the open market, by 6 insiders. Newest filing Aug 18, 2026 (1 month ago).
Net Insider Buying by Quarter
Shares bought (+) or sold (−) on the open market by LH insiders · Form 4 · last two years
On Record
$0Purchases · 180 days
$5.0MSales · 180 days
2,209Open-market transactions on record
6Insiders filing · 180 days
Purchases (code P) and sales (code S) of LH common stock reported on Form 4, with Form 5 annual catch-ups. Grants, option exercises, gifts and tax withholding are not shown. Dollars are shares × the stated price; a price outside anything the stock traded at that day is withheld (n/c).
Insider Transactions
2,209 on record · newest trade first · the newest 300 shown
AllPurchasesSalesOfficers & directors
| Insider | Type | Shares | Price | Value | Held after | Traded | Filed | |
|---|---|---|---|---|---|---|---|---|
| ANDERSON KERRII BDirector · Director | Sale | −3,000 | $318.02 | $954K | 6,563direct | Aug 17, 2026 | Aug 18, 2026 | Form 4 ↗ |
| Schechter Adam HPresident & CEO · Director | Sale | −4,669 | $320.37 | $1.5M | 102.6Kdirect | Aug 11, 2026 | Aug 12, 2026 | Form 4 ↗ |
| Summy Amy B.EVP, Chief Marketing Officer | Sale | −924 | $306.74 | $283K | 6,956direct | Aug 4, 2026 | Aug 6, 2026 | Form 4 ↗ |
| Wilkinson Peter JSVP, Chief Accounting Officer | Sale | −82 | $309.22 | $25K | 1,770direct | Aug 3, 2026 | Aug 5, 2026 | Form 4 ↗ |
| Wilkinson Peter JSVP, Chief Accounting Officer | Sale | −1,338 | $309.23 | $414K | 1,770direct | Aug 3, 2026 | Aug 5, 2026 | Form 4 ↗ |
| Kyle Kathryn WEVP, Chief Legal Officer | Sale | −92 | $286.19 | $26K | 3,904direct | Jul 2, 2026 | Jul 6, 2026 | Form 4 ↗ |
| Vaughn Bryan TEVP and President, Diagnostics | Sale | −234 | $286.19 | $67K | 6,746direct | Jul 2, 2026 | Jul 6, 2026 | Form 4 ↗ |
| Kyle Kathryn WEVP, Chief Legal Officer | Sale | −762 | $263.89 | $201K | 3,813direct | Jun 8, 2026 | Jun 10, 2026 | Form 4 ↗ |
| Schechter Adam HPresident & CEO · Director | Sale | −5,903 | $254.50 | $1.5M | 107.2Kdirect | May 11, 2026 | May 13, 2026 | Form 4 ↗ |
| Wilkinson Peter JSVP, Chief Accounting Officer | Sale | −1,633 | $267.05 | $436K | 1,852direct | Mar 27, 2026 | Mar 30, 2026 | Form 4 ↗ |
| Meltzer Jonathan CEVP, Operations | Sale | −839 | $267.05 | $224K | 3,620direct | Mar 27, 2026 | Mar 30, 2026 | Form 4 ↗ |
| Schechter Adam HPresident & CEO · Director | Sale | −8,705 | $279.96 | $2.4M | 80.8Kdirect | Mar 3, 2026 | Mar 5, 2026 | Form 4 ↗ |
| van der Vaart Sandra DEVP, Corporate Affairs | Sale | −548 | $284.91 | $156K | 2,579direct | Feb 27, 2026 | Mar 3, 2026 | Form 4 ↗ |
| Caveney Brian JEVP, Pres of ED, CMO & CSO | Sale | −1,500 | $286.31 | $429K | 30.1Kdirect | Feb 24, 2026 | Feb 26, 2026 | Form 4 ↗ |
| Wilkinson Peter JSVP, Chief Accounting Officer | Sale | −666 | $277.94 | $185K | 1,852direct | Feb 19, 2026 | Feb 23, 2026 | Form 4 ↗ |
| Meltzer Jonathan CEVP, Operations | Sale | −87 | $290.42 | $25K | 2,782direct | Feb 12, 2026 | Feb 13, 2026 | Form 4 ↗ |
| Schechter Adam HPresident & CEO · Director | Sale | −5,273 | $284.38 | $1.5M | 87.3Kdirect | Feb 11, 2026 | Feb 13, 2026 | Form 4 ↗ |
| Meltzer Jonathan CEVP, Operations | Sale | −91 | $276.79 | $25K | 2,696direct | Feb 10, 2026 | Feb 12, 2026 | Form 4 ↗ |
| Meltzer Jonathan CEVP, Operations | Sale | −88 | $275.53 | $24K | 2,869direct | Feb 9, 2026 | Feb 10, 2026 | Form 4 ↗ |
| Schechter Adam HPresident & CEO · Director | Sale | −5,745 | $262.75 | $1.5M | 87.6Kdirect | Nov 11, 2025 | Nov 13, 2025 | Form 4 ↗ |
| Parham Richelle PDirector | Sale | −7,009 | $254.28 | $1.8M | 2,469direct | Oct 31, 2025 | Nov 4, 2025 | Form 4 ↗ |
| van der Vaart Sandra DEVP, Chief Legal Officer | Sale | −3,903 | $271.42 | $1.1M | 2,274direct | Aug 13, 2025 | Aug 15, 2025 | Form 4 ↗ |
| Schechter Adam HPresident & CEO · Director | Sale | −5,643 | $266.78 | $1.5M | 93.3Kdirect | Aug 11, 2025 | Aug 13, 2025 | Form 4 ↗ |
| Gilliland Dwight GaryDirector | Sale | −2,000 | $264.95 | $530K | 6,656direct | Jul 30, 2025 | Aug 1, 2025 | Form 4 ↗ |
| Wilkinson Peter JSVP, Chief Accounting Officer | Sale | −100 | $261.04 | $26K | 1,852direct | Jul 29, 2025 | Jul 31, 2025 | Form 4 ↗ |
| Wilkinson Peter JSVP, Chief Accounting Officer | Sale | −102 | $261.01 | $27K | 1,952direct | Jul 29, 2025 | Jul 31, 2025 | Form 4 ↗ |
| ANDERSON KERRII BDirector | Sale | −3,500 | $280.00 | $980K | 8,666direct | Jul 24, 2025 | Jul 28, 2025 | Form 4 ↗ |
| ANDERSON KERRII BDirector | Sale | −3,500 | $280.00 | $980K | 8,666direct | Jul 24, 2025 | Jul 28, 2025 | Form 4 ↗ |
| ANDERSON KERRII BDirector | Sale | −500 | $265.00 | $133K | 12.2Kdirect | Jul 1, 2025 | Jul 2, 2025 | Form 4 ↗ |
| ANDERSON KERRII BDirector | Sale | −500 | $260.00 | $130K | 12.7Kdirect | Jun 11, 2025 | Jun 12, 2025 | Form 4 ↗ |
| Caveney Brian JEVP, Pres of ED, CMO & CSO | Sale | −2,000 | $247.00 | $494K | 30.1Kdirect | Jun 3, 2025 | Jun 5, 2025 | Form 4 ↗ |
| Schechter Adam HPresident & CEO · Director | Sale | −6,105 | $248.73 | $1.5M | 99.0Kdirect | May 12, 2025 | May 13, 2025 | Form 4 ↗ |
| van der Vaart Sandra DEVP, Chief Legal Officer | Sale | −1,900 | $238.36 | $453K | 2,244direct | May 1, 2025 | May 5, 2025 | Form 4 ↗ |
| Wilkinson Peter JSVP, Chief Accounting Officer | Sale | −829 | $242.27 | $201K | 2,054direct | May 1, 2025 | May 5, 2025 | Form 4 ↗ |
| Summy Amy B.EVP, Chief Marketing Officer | Sale | −758 | $231.67 | $176K | 5,302direct | Mar 28, 2025 | Mar 31, 2025 | Form 4 ↗ |
| Schroeder Mark SEVP, Pres Diagnostics & COO | Sale | −2,635 | $231.67 | $610K | 4,960direct | Mar 28, 2025 | Mar 31, 2025 | Form 4 ↗ |
| ANDERSON KERRII BDirector | Sale | −500 | $255.63 | $128K | 13.2Kdirect | Mar 5, 2025 | Mar 7, 2025 | Form 4 ↗ |
| Schroeder Mark SEVP, Pres Diagnostics & COO | Sale | −5,339 | $249.23 | $1.3M | 4,960direct | Feb 28, 2025 | Mar 4, 2025 | Form 4 ↗ |
| van der Vaart Sandra DEVP, Chief Legal Officer | Sale | −1,314 | $251.30 | $330K | 2,171direct | Feb 25, 2025 | Feb 27, 2025 | Form 4 ↗ |
| Summy Amy B.EVP, Chief Marketing Officer | Sale | −226 | $250.40 | $57K | 4,545direct | Feb 24, 2025 | Feb 26, 2025 | Form 4 ↗ |
| Wilkinson Peter JSVP, Chief Accounting Officer | Sale | −1,413 | $246.10 | $348K | 1,993direct | Feb 18, 2025 | Feb 20, 2025 | Form 4 ↗ |
| Schechter Adam HPresident & CEO · Director | Sale | −6,121 | $244.62 | $1.5M | 86.4Kdirect | Feb 11, 2025 | Feb 13, 2025 | Form 4 ↗ |
| ANDERSON KERRII BDirector | Sale | −1,000 | $235.00 | $235K | 12.7Kdirect | Jan 7, 2025 | Jan 8, 2025 | Form 4 ↗ |
| EISENBERG GLENN AExecutive Vice President | Sale | −11.7K | $240.43 | $2.8M | 31.3Kdirect | Dec 2, 2024 | Dec 4, 2024 | Form 4 ↗ |
| Gilliland Dwight GaryDirector | Sale | −1,000 | $241.00 | $241K | 7,712direct | Dec 2, 2024 | Dec 4, 2024 | Form 4 ↗ |
| Summy Amy B.EVP, Chief Marketing Officer | Sale | −3,672 | $238.91 | $877K | 4,319direct | Nov 22, 2024 | Nov 26, 2024 | Form 4 ↗ |
| van der Vaart Sandra DEVP, Chief Legal Officer | Sale | −1,000 | $239.42 | $239K | 2,670direct | Nov 21, 2024 | Nov 25, 2024 | Form 4 ↗ |
| Schechter Adam HPresident & CEO · Director | Sale | −6,189 | $243.47 | $1.5M | 87.4Kdirect | Nov 11, 2024 | Nov 13, 2024 | Form 4 ↗ |
| ANDERSON KERRII BDirector | Sale | −1,000 | $230.00 | $230K | 13.7Kdirect | Oct 24, 2024 | Oct 25, 2024 | Form 4 ↗ |
| van der Vaart Sandra DEVP, Chief Legal Officer | Sale | −2,000 | $227.05 | $454K | 3,670direct | Aug 19, 2024 | Aug 21, 2024 | Form 4 ↗ |
| EISENBERG GLENN AChief Financial Officer, EVP | Sale | −9,071 | $224.55 | $2.0M | 31.3Kdirect | Aug 15, 2024 | Aug 19, 2024 | Form 4 ↗ |
| EISENBERG GLENN AChief Financial Officer, EVP | Sale | −2,950 | $223.62 | $660K | 40.4Kdirect | Aug 15, 2024 | Aug 19, 2024 | Form 4 ↗ |
| EISENBERG GLENN AChief Financial Officer, EVP | Sale | −2,979 | $222.65 | $663K | 43.3Kdirect | Aug 15, 2024 | Aug 19, 2024 | Form 4 ↗ |
| ANDERSON KERRII BDirector | Sale | −586 | $225.00 | $132K | 14.7Kdirect | Aug 8, 2024 | Aug 9, 2024 | Form 4 ↗ |
| ANDERSON KERRII BDirector | Sale | −414 | $225.00 | $93K | 15.3Kdirect | Aug 7, 2024 | Aug 9, 2024 | Form 4 ↗ |
| BERBERIAN LANCEEVP, CIO & CTO | Sale | −9,848 | $228.95 | $2.3M | 15.9Kdirect | Aug 5, 2024 | Aug 7, 2024 | Form 4 ↗ |
| BERBERIAN LANCEEVP, CIO & CTO | Sale | −2,245 | $229.79 | $516K | 25.8Kdirect | Aug 5, 2024 | Aug 7, 2024 | Form 4 ↗ |
| van der Vaart Sandra DEVP, Chief Legal Officer | Sale | −200 | $210.84 | $42K | 5,637direct | May 14, 2024 | May 16, 2024 | Form 4 ↗ |
| van der Vaart Sandra DEVP, Chief Legal Officer | Sale | −1,800 | $210.83 | $379K | 5,837direct | May 14, 2024 | May 16, 2024 | Form 4 ↗ |
| ANDERSON KERRII BDirector | Sale | −250 | $200.10 | $50K | 15.7Kdirect | May 2, 2024 | May 2, 2024 | Form 4 ↗ |
| ANDERSON KERRII BDirector | Sale | −250 | $204.14 | $51K | 16.0Kdirect | Apr 30, 2024 | May 2, 2024 | Form 4 ↗ |
| Wilkinson Peter JSVP, Chief Accounting Officer | Sale | −2,439 | $204.33 | $498K | 2,087direct | Apr 29, 2024 | May 1, 2024 | Form 4 ↗ |
| Schroeder Mark SEVP, Pres Diagnostics & COO | Sale | −6,477 | $217.29 | $1.4M | 5,036direct | Apr 1, 2024 | Apr 3, 2024 | Form 4 ↗ |
| Summy Amy B.EVP, Chief Marketing Officer | Sale | −3,500 | $217.29 | $761K | 3,975direct | Apr 1, 2024 | Apr 3, 2024 | Form 4 ↗ |
| van der Vaart Sandra DEVP, Chief Legal Officer | Sale | −3,553 | $216.74 | $770K | 7,637direct | Mar 28, 2024 | Mar 29, 2024 | Form 4 ↗ |
| Schroeder Mark SEVP, Pres Diagnostics & COO | Sale | −5,048 | $218.45 | $1.1M | 5,036direct | Mar 7, 2024 | Mar 11, 2024 | Form 4 ↗ |
| Summy Amy B.EVP, Chief Marketing Officer | Sale | −227 | $218.45 | $50K | 3,859direct | Mar 7, 2024 | Mar 11, 2024 | Form 4 ↗ |
| EISENBERG GLENN AChief Financial Officer, EVP | Sale | −1,553 | $217.98 | $339K | 23.6Kdirect | Feb 21, 2024 | Feb 22, 2024 | Form 4 ↗ |
| EISENBERG GLENN AChief Financial Officer, EVP | Sale | −6,665 | $217.52 | $1.4M | 25.1Kdirect | Feb 21, 2024 | Feb 22, 2024 | Form 4 ↗ |
| EISENBERG GLENN AChief Financial Officer, EVP | Sale | −7,907 | $215.68 | $1.7M | 31.8Kdirect | Feb 21, 2024 | Feb 22, 2024 | Form 4 ↗ |
| EISENBERG GLENN AChief Financial Officer, EVP | Sale | −18.4K | $215.37 | $4.0M | 39.7Kdirect | Feb 21, 2024 | Feb 22, 2024 | Form 4 ↗ |
| DiVincenzo Jonathan P.EVP, Pres, Central Labs & Intl | Sale | −500 | $215.49 | $108K | 3,401direct | Feb 21, 2024 | Feb 22, 2024 | Form 4 ↗ |
| van der Vaart Sandra DEVP, Chief Legal Officer | Sale | −237 | $226.45 | $54K | 7,637direct | Feb 13, 2024 | Feb 15, 2024 | Form 4 ↗ |
| van der Vaart Sandra DEVP, Chief Legal Officer | Sale | −259 | $222.06 | $58K | 7,637direct | Feb 8, 2024 | Feb 9, 2024 | Form 4 ↗ |
| van der Vaart Sandra DEVP, Chief Legal Officer | Sale | −193 | $220.57 | $43K | 7,637direct | Feb 5, 2024 | Feb 6, 2024 | Form 4 ↗ |
| Wilkinson Peter JSVP, Chief Accounting Officer | Sale | −1,384 | $210.71 | $292K | 2,087direct | Nov 16, 2023 | Nov 20, 2023 | Form 4 ↗ |
| ANDERSON KERRII BDirector | Sale | −5,000 | $211.57 | $1.1M | 15.3Kdirect | Aug 8, 2023 | Aug 10, 2023 | Form 4 ↗ |
| van der Vaart Sandra DEVP, Chief Legal Officer | Sale | −212 | $240.00 | $51K | 7,605direct | Jun 29, 2023 | Jul 3, 2023 | Form 4 ↗ |
| Kirchgraber Paul RCEO, Covance Drug Development | Sale | −4,300 | $216.91 | $933K | 12.9Kdirect | May 19, 2023 | May 23, 2023 | Form 4 ↗ |
| Schroeder Mark SEVP, Pres Diagnostics & COO | Sale | −1,500 | $216.77 | $325K | 6,687direct | May 18, 2023 | May 22, 2023 | Form 4 ↗ |
| Schroeder Mark SEVP, President-Diagnostics Lab | Sale | −3,897 | $225.81 | $880K | 6,687direct | Mar 31, 2023 | Apr 3, 2023 | Form 4 ↗ |
| Kirchgraber Paul RCEO, Covance Drug Development | Sale | −8,000 | $250.58 | $2.0M | 9,069direct | Feb 21, 2023 | Feb 23, 2023 | Form 4 ↗ |
| Schroeder Mark SEVP, President-Diagnostics Lab | Sale | −309 | $247.63 | $77K | 6,687direct | Feb 14, 2023 | Feb 16, 2023 | Form 4 ↗ |
| van der Vaart Sandra DEVP, Chief Legal Officer | Sale | −219 | $243.01 | $53K | 5,341direct | Feb 7, 2023 | Feb 9, 2023 | Form 4 ↗ |
| Schroeder Mark SEVP, President-Diagnostics Lab | Sale | −409 | $243.01 | $99K | 6,687direct | Feb 7, 2023 | Feb 9, 2023 | Form 4 ↗ |
| van der Vaart Sandra DEVP, Chief Legal Officer | Sale | −173 | $253.90 | $44K | 5,341direct | Feb 3, 2023 | Feb 6, 2023 | Form 4 ↗ |
| Schroeder Mark SEVP, President-Diagnostics Lab | Sale | −324 | $253.90 | $82K | 6,687direct | Feb 3, 2023 | Feb 6, 2023 | Form 4 ↗ |
| Schroeder Mark SEVP, President-Diagnostics Lab | Sale | −1,116 | $232.67 | $260K | 6,687direct | Nov 8, 2022 | Nov 10, 2022 | Form 4 ↗ |
| EISENBERG GLENN AChief Financial Officer, EVP | Sale | −2,830 | $211.86 | $600K | 27.2Kdirect | Sep 26, 2022 | Sep 28, 2022 | Form 4 ↗ |
| EISENBERG GLENN AChief Financial Officer, EVP | Sale | −11.7K | $211.13 | $2.5M | 30.0Kdirect | Sep 26, 2022 | Sep 28, 2022 | Form 4 ↗ |
| EISENBERG GLENN AChief Financial Officer, EVP | Sale | −4,844 | $210.21 | $1.0M | 41.7Kdirect | Sep 26, 2022 | Sep 28, 2022 | Form 4 ↗ |
| EISENBERG GLENN AChief Financial Officer, EVP | Sale | −5,627 | $209.29 | $1.2M | 46.5Kdirect | Sep 26, 2022 | Sep 28, 2022 | Form 4 ↗ |
| Caveney Brian JEVP, President of Diagnostics | Purchase | +44 | $231.20 | $10K | 14.3Kdirect | Sep 7, 2022 | Sep 13, 2022 | Form 4 ↗ |
| EISENBERG GLENN AChief Financial Officer, EVP | Sale | −1,500 | $254.88 | $382K | 52.2Kdirect | Aug 3, 2022 | Aug 5, 2022 | Form 4 ↗ |
| EISENBERG GLENN AChief Financial Officer, EVP | Sale | −19.3K | $254.26 | $4.9M | 53.7Kdirect | Aug 3, 2022 | Aug 5, 2022 | Form 4 ↗ |
| EISENBERG GLENN AChief Financial Officer, EVP | Sale | −11.3K | $253.27 | $2.9M | 73.0Kdirect | Aug 3, 2022 | Aug 5, 2022 | Form 4 ↗ |
| Wilkinson Peter JSVP, Chief Accounting Officer | Sale | −10 | $258.71 | $3K | 1,887direct | Aug 1, 2022 | Aug 3, 2022 | Form 4 ↗ |
| Wilkinson Peter JSVP, Chief Accounting Officer | Sale | −757 | $258.60 | $196K | 1,897direct | Aug 1, 2022 | Aug 3, 2022 | Form 4 ↗ |
| Wilkinson Peter JSVP, Chief Accounting Officer | Sale | −1,809 | $258.31 | $467K | 1,887direct | Aug 1, 2022 | Aug 3, 2022 | Form 4 ↗ |
| Caveney Brian JEVP, President of Diagnostics | Purchase | +42 | $242.19 | $10K | 14.2Kdirect | Jun 7, 2022 | Jun 14, 2022 | Form 4 ↗ |
| Schroeder Mark SEVP, President-Diagnostics Lab | Sale | −2,356 | $277.11 | $653K | 6,606direct | Mar 29, 2022 | Mar 31, 2022 | Form 4 ↗ |
| van der Vaart Sandra DEVP, Chief Legal Officer | Sale | −2,449 | $277.11 | $679K | 5,287direct | Mar 29, 2022 | Mar 31, 2022 | Form 4 ↗ |
| Williams R SandersDirector | Sale | −572 | $272.98 | $156K | 6,431direct | Mar 25, 2022 | Mar 29, 2022 | Form 4 ↗ |
| Summy Amy B.EVP, Chief Marketing Officer | Sale | −249 | $262.21 | $65K | 250direct | Mar 10, 2022 | Mar 14, 2022 | Form 4 ↗ |
| NEUPERT PETER MDirector | Purchase | +600 | $264.57 | $159K | 10.3Kdirect | Feb 16, 2022 | Feb 18, 2022 | Form 4 ↗ |
| NEUPERT PETER MDirector | Purchase | +1,600 | $263.98 | $422K | 9,654direct | Feb 16, 2022 | Feb 18, 2022 | Form 4 ↗ |
| NEUPERT PETER MDirector | Purchase | +1,300 | $262.85 | $342K | 8,054direct | Feb 16, 2022 | Feb 18, 2022 | Form 4 ↗ |
| Schroeder Mark SEVP, President-Diagnostics Lab | Sale | −207 | $273.98 | $57K | 6,606direct | Feb 15, 2022 | Feb 17, 2022 | Form 4 ↗ |
| van der Vaart Sandra DEVP, Chief Legal Officer | Sale | −207 | $273.98 | $57K | 5,287direct | Feb 15, 2022 | Feb 17, 2022 | Form 4 ↗ |
| Schroeder Mark SEVP, President-Diagnostics Lab | Sale | −204 | $277.38 | $57K | 6,606direct | Feb 7, 2022 | Feb 8, 2022 | Form 4 ↗ |
| van der Vaart Sandra DEVP, Chief Legal Officer | Sale | −218 | $277.38 | $60K | 5,287direct | Feb 7, 2022 | Feb 8, 2022 | Form 4 ↗ |
| Schroeder Mark SEVP, President-Diagnostics Lab | Sale | −161 | $271.81 | $44K | 6,402direct | Feb 3, 2022 | Feb 4, 2022 | Form 4 ↗ |
| van der Vaart Sandra DEVP, Chief Legal Officer | Sale | −172 | $271.81 | $47K | 5,287direct | Feb 3, 2022 | Feb 4, 2022 | Form 4 ↗ |
| Gilliland Dwight GaryDirector | Sale | −18 | $302.31 | $5K | 6,252direct | Dec 15, 2021 | Dec 17, 2021 | Form 4 ↗ |
| Gilliland Dwight GaryDirector | Sale | −25 | $302.28 | $8K | 6,270direct | Dec 15, 2021 | Dec 17, 2021 | Form 4 ↗ |
| Gilliland Dwight GaryDirector | Sale | −100 | $302.26 | $30K | 6,295direct | Dec 15, 2021 | Dec 17, 2021 | Form 4 ↗ |
| Gilliland Dwight GaryDirector | Sale | −357 | $302.25 | $108K | 6,395direct | Dec 15, 2021 | Dec 17, 2021 | Form 4 ↗ |
| van der Vaart Sandra DEVP, Chief Legal Officer | Sale | −4,500 | $296.78 | $1.3M | 5,265direct | Sep 15, 2021 | Sep 17, 2021 | Form 4 ↗ |
| van der Vaart Sandra DEVP, Chief Legal Officer | Sale | −4,500 | $266.56 | $1.2M | 5,237direct | Jun 7, 2021 | Jun 9, 2021 | Form 4 ↗ |
| Kirchgraber Paul RCEO, Covance Drug Development | Sale | −2,500 | $276.55 | $691K | 7,844direct | May 6, 2021 | May 10, 2021 | Form 4 ↗ |
| BELINGARD JEAN-LUCDirector | Sale | −2,600 | $269.16 | $700K | 15.6Kdirect | May 3, 2021 | May 5, 2021 | Form 4 ↗ |
| Schroeder Mark SEVP, President-Diagnostics Lab | Sale | −667 | $251.88 | $168K | 5,006direct | Mar 30, 2021 | Apr 1, 2021 | Form 4 ↗ |
| van der Vaart Sandra DEVP, Chief Legal Officer | Sale | −812 | $251.88 | $205K | 5,237direct | Mar 30, 2021 | Apr 1, 2021 | Form 4 ↗ |
| Wilkinson Peter JSVP, Chief Accounting Officer | Sale | −2,317 | $241.51 | $560K | 343direct | Feb 18, 2021 | Feb 19, 2021 | Form 4 ↗ |
| van der Vaart Sandra DEVP, Chief Legal Officer | Sale | −100 | $236.05 | $24K | 4,426direct | Feb 16, 2021 | Feb 17, 2021 | Form 4 ↗ |
| van der Vaart Sandra DEVP, Chief Legal Officer | Sale | −5 | $235.89 | $1K | 4,526direct | Feb 16, 2021 | Feb 17, 2021 | Form 4 ↗ |
| van der Vaart Sandra DEVP, Chief Legal Officer | Sale | −103 | $237.06 | $24K | 4,531direct | Feb 16, 2021 | Feb 17, 2021 | Form 4 ↗ |
| Schroeder Mark SEVP, President-Diagnostics Lab | Sale | −85 | $237.06 | $20K | 4,339direct | Feb 16, 2021 | Feb 17, 2021 | Form 4 ↗ |
| Schroeder Mark SEVP, President-Diagnostics Lab | Sale | −103 | $237.06 | $24K | 4,424direct | Feb 16, 2021 | Feb 17, 2021 | Form 4 ↗ |
| van der Vaart Sandra DEVP, Chief Legal Officer | Sale | −109 | $225.85 | $25K | 4,219direct | Feb 5, 2021 | Feb 8, 2021 | Form 4 ↗ |
| Schroeder Mark SEVP, President-Diagnostics Lab | Sale | −203 | $225.85 | $46K | 4,152direct | Feb 5, 2021 | Feb 8, 2021 | Form 4 ↗ |
| Schroeder Mark SEVP, President-Diagnostics Lab | Sale | −588 | $214.59 | $126K | 3,949direct | Nov 6, 2020 | Nov 10, 2020 | Form 4 ↗ |
| Kirchgraber Paul RCEO, Covance Drug Development | Sale | −1,500 | $214.14 | $321K | 7,698direct | Nov 4, 2020 | Nov 6, 2020 | Form 4 ↗ |
| Williams R SandersDirector | Sale | −1,300 | $173.12 | $225K | 5,095direct | Jul 8, 2020 | Jul 10, 2020 | Form 4 ↗ |
| van der Vaart Sandra DEVP, Chief Legal Officer | Sale | −435 | $170.00 | $74K | 4,044direct | Jul 2, 2020 | Jul 7, 2020 | Form 4 ↗ |
| van der Vaart Sandra DEVP, Chief Legal Officer | Sale | −436 | $160.33 | $70K | 4,479direct | Jun 24, 2020 | Jun 26, 2020 | Form 4 ↗ |
| van der Vaart Sandra DEVP, Chief Legal Officer | Sale | −436 | $160.33 | $70K | 4,915direct | Jun 24, 2020 | Jun 26, 2020 | Form 4 ↗ |
| KING DAVID PDirector | Sale | −31.3K | $160.00 | $5.0M | 312.6Kdirect | May 5, 2020 | May 7, 2020 | Form 4 ↗ |
| Seltz Judith CEVP, CHRO | Purchase | +330 | $168.56 | $56K | 580direct | Mar 10, 2020 | May 4, 2020 | Form 4 ↗ |
| Seltz Judith CEVP, CHRO | Purchase | +250 | $174.94 | $44K | 250direct | Feb 28, 2020 | May 4, 2020 | Form 4 ↗ |
| Wilkinson Peter JSVP, Chief Accounting Officer | Sale | −297 | $189.65 | $56K | 297direct | Feb 21, 2020 | Feb 25, 2020 | Form 4 ↗ |
| BELINGARD JEAN-LUCDirector | Sale | −26.5K | $189.76 | $5.0M | 14.7Kdirect | Feb 19, 2020 | Feb 21, 2020 | Form 4 ↗ |
| van der Vaart Sandra DSVP, Global General Counsel | Sale | −103 | $188.49 | $19K | 2,736direct | Feb 13, 2020 | Feb 14, 2020 | Form 4 ↗ |
| van der Vaart Sandra DSVP, Global General Counsel | Sale | −105 | $188.49 | $20K | 2,839direct | Feb 13, 2020 | Feb 14, 2020 | Form 4 ↗ |
| Schroeder Mark SEVP, President-Diagnostics Lab | Sale | −103 | $188.49 | $19K | 486direct | Feb 13, 2020 | Feb 14, 2020 | Form 4 ↗ |
| Schroeder Mark SEVP, President-Diagnostics Lab | Sale | −85 | $188.49 | $16K | 589direct | Feb 13, 2020 | Feb 14, 2020 | Form 4 ↗ |
| Williams R SandersDirector | Sale | −1,227 | $188.49 | $231K | 5,095direct | Feb 13, 2020 | Feb 14, 2020 | Form 4 ↗ |
| Schroeder Mark SEVP, President-Diagnostics Lab | Sale | −108 | $181.99 | $20K | 300direct | Feb 10, 2020 | Feb 11, 2020 | Form 4 ↗ |
| van der Vaart Sandra DSVP, Global General Counsel | Sale | −133 | $181.99 | $24K | 2,529direct | Feb 10, 2020 | Feb 11, 2020 | Form 4 ↗ |
| KING DAVID PPresident & CEO · Director | Sale | −12.4K | $166.21 | $2.1M | 305.9Kdirect | Oct 28, 2019 | Oct 30, 2019 | Form 4 ↗ |
| KING DAVID PPresident & CEO · Director | Sale | −10.4K | $165.32 | $1.7M | 318.3Kdirect | Oct 28, 2019 | Oct 30, 2019 | Form 4 ↗ |
| KING DAVID PPresident & CEO · Director | Sale | −7,434 | $164.16 | $1.2M | 328.7Kdirect | Oct 28, 2019 | Oct 30, 2019 | Form 4 ↗ |
| ANDERSON KERRII BDirector | Sale | −2,600 | $171.85 | $447K | 17.9Kdirect | Sep 23, 2019 | Sep 25, 2019 | Form 4 ↗ |
| Uthgenannt Lisa JChief Human Resources Officer | Sale | −2,466 | $168.59 | $416K | 4,660direct | Sep 4, 2019 | Sep 6, 2019 | Form 4 ↗ |
| BERBERIAN LANCESVP, Chief Information Officer | Sale | −5,902 | $169.80 | $1.0M | 6,097direct | Aug 30, 2019 | Sep 4, 2019 | Form 4 ↗ |
| Williams R SandersDirector | Sale | −500 | $162.91 | $81K | 6,886direct | Aug 5, 2019 | Aug 7, 2019 | Form 4 ↗ |
| EISENBERG GLENN AChief Financial Officer, EVP | Sale | −5,563 | $176.75 | $983K | 17.1Kdirect | Jul 8, 2019 | Jul 10, 2019 | Form 4 ↗ |
| van der Vaart Sandra DSVP, Global General Counsel | Sale | −2,328 | $176.75 | $411K | 2,328direct | Jul 8, 2019 | Jul 10, 2019 | Form 4 ↗ |
| ANDERSON KERRII BDirector | Sale | −3,100 | $170.00 | $527K | 19.1Kdirect | Jun 20, 2019 | Jun 21, 2019 | Form 4 ↗ |
| EISENBERG GLENN AChief Financial Officer, EVP | Sale | −1,294 | $168.41 | $218K | 22.6Kdirect | Jun 7, 2019 | Jun 11, 2019 | Form 4 ↗ |
| EISENBERG GLENN AChief Financial Officer, EVP | Sale | −4,450 | $167.65 | $746K | 23.9Kdirect | Jun 7, 2019 | Jun 11, 2019 | Form 4 ↗ |
| EISENBERG GLENN AChief Financial Officer, EVP | Sale | −4,256 | $166.82 | $710K | 28.4Kdirect | Jun 7, 2019 | Jun 11, 2019 | Form 4 ↗ |
| Williams R SandersDirector | Sale | −500 | $162.20 | $81K | 7,386direct | May 6, 2019 | May 8, 2019 | Form 4 ↗ |
| MITTELSTAEDT ROBERT E JRDirector | Sale | −3,700 | $166.30 | $615K | 15.2Kdirect | May 3, 2019 | May 7, 2019 | Form 4 ↗ |
| Uthgenannt Lisa JChief Human Resources Officer | Sale | −4,000 | $164.00 | $656K | 4,638direct | May 2, 2019 | May 6, 2019 | Form 4 ↗ |
| Williams R SandersDirector | Sale | −1,038 | $147.00 | $153K | 7,886direct | Feb 13, 2019 | Feb 14, 2019 | Form 4 ↗ |
| BELINGARD JEAN-LUCDirector | Sale | −3,700 | $146.06 | $540K | 33.1Kdirect | Feb 12, 2019 | Feb 14, 2019 | Form 4 ↗ |
| Williams R SandersDirector | Sale | −350 | $162.14 | $57K | 7,886direct | Nov 27, 2018 | Nov 29, 2018 | Form 4 ↗ |
| ANDERSON KERRII BDirector | Sale | −3,700 | $163.29 | $604K | 18.1Kdirect | Nov 5, 2018 | Nov 7, 2018 | Form 4 ↗ |
| Dodson Edward TPrincipal Accounting Officer | Sale | −13.0K | $183.35 | $2.4M | 9,113direct | Jun 6, 2018 | Jun 8, 2018 | Form 4 ↗ |
| Uthgenannt Lisa JChief Human Resources Officer | Sale | −4,500 | $182.10 | $819K | 3,755direct | Jun 4, 2018 | Jun 6, 2018 | Form 4 ↗ |
| Gilliland Dwight GaryDirector | Sale | −400 | $181.30 | $73K | 3,501direct | May 31, 2018 | Jun 4, 2018 | Form 4 ↗ |
| Gilliland Dwight GaryDirector | Sale | −300 | $181.29 | $54K | 3,901direct | May 31, 2018 | Jun 4, 2018 | Form 4 ↗ |
| Gilliland Dwight GaryDirector | Sale | −436 | $181.29 | $79K | 4,201direct | May 31, 2018 | Jun 4, 2018 | Form 4 ↗ |
| Gilliland Dwight GaryDirector | Sale | −127 | $181.26 | $23K | 4,637direct | May 31, 2018 | Jun 4, 2018 | Form 4 ↗ |
| BERBERIAN LANCESVP, Chief Information Officer | Sale | −315 | $182.37 | $57K | 5,940direct | May 31, 2018 | Jun 4, 2018 | Form 4 ↗ |
| BERBERIAN LANCESVP, Chief Information Officer | Sale | −5,185 | $182.30 | $945K | 6,255direct | May 31, 2018 | Jun 4, 2018 | Form 4 ↗ |
| Gary M. HuffCEO, LabCorp Diagnostics | Sale | −1,610 | $182.50 | $294K | 1,610direct | May 30, 2018 | Jun 1, 2018 | Form 4 ↗ |
| EISENBERG GLENN AChief Financial Officer, EVP | Sale | −3,280 | $181.50 | $595K | 15.6Kdirect | May 30, 2018 | Jun 1, 2018 | Form 4 ↗ |
| EISENBERG GLENN AChief Financial Officer, EVP | Sale | −6,720 | $181.06 | $1.2M | 18.8Kdirect | May 30, 2018 | Jun 1, 2018 | Form 4 ↗ |
| KING DAVID PPresident & CEO · Director | Sale | −5,400 | $176.13 | $951K | 221.7Kdirect | May 23, 2018 | May 25, 2018 | Form 4 ↗ |
| KING DAVID PPresident & CEO · Director | Sale | −44.6K | $175.27 | $7.8M | 227.1Kdirect | May 23, 2018 | May 25, 2018 | Form 4 ↗ |
| KING DAVID PPresident & CEO · Director | Sale | −21.2K | $166.37 | $3.5M | 221.7Kdirect | Apr 23, 2018 | Apr 25, 2018 | Form 4 ↗ |
| KING DAVID PPresident & CEO · Director | Sale | −28.8K | $165.94 | $4.8M | 242.9Kdirect | Apr 23, 2018 | Apr 25, 2018 | Form 4 ↗ |
| KING DAVID PPresident & CEO · Director | Sale | −1,700 | $166.38 | $283K | 181.2Kdirect | Mar 23, 2018 | Mar 27, 2018 | Form 4 ↗ |
| KING DAVID PPresident & CEO · Director | Sale | −10.3K | $165.39 | $1.7M | 182.9Kdirect | Mar 23, 2018 | Mar 27, 2018 | Form 4 ↗ |
| KING DAVID PPresident & CEO · Director | Sale | −36.3K | $164.55 | $6.0M | 193.2Kdirect | Mar 23, 2018 | Mar 27, 2018 | Form 4 ↗ |
| KING DAVID PPresident & CEO · Director | Sale | −1,689 | $163.58 | $276K | 229.5Kdirect | Mar 23, 2018 | Mar 27, 2018 | Form 4 ↗ |
| EISENBERG GLENN AChief Financial Officer, EVP | Sale | −500 | $168.61 | $84K | 13.8Kdirect | Feb 12, 2018 | Feb 14, 2018 | Form 4 ↗ |
| EISENBERG GLENN AChief Financial Officer, EVP | Sale | −1,600 | $167.78 | $268K | 14.3Kdirect | Feb 12, 2018 | Feb 14, 2018 | Form 4 ↗ |
| EISENBERG GLENN AChief Financial Officer, EVP | Sale | −6,300 | $167.16 | $1.1M | 15.9Kdirect | Feb 12, 2018 | Feb 14, 2018 | Form 4 ↗ |
| ANDERSON KERRII BDirector | Sale | −3,300 | $166.10 | $548K | 18.1Kdirect | Feb 9, 2018 | Feb 13, 2018 | Form 4 ↗ |
| Schechter Adam HDirector | Sale | −1,263 | $169.29 | $214K | 6,034direct | Feb 8, 2018 | Feb 9, 2018 | Form 4 ↗ |
| Gilliland Dwight GaryDirector | Sale | −971 | $153.52 | $149K | 3,501direct | Oct 30, 2017 | Nov 1, 2017 | Form 4 ↗ |
| KING DAVID PPresident & CEO · Director | Sale | −7,500 | $157.34 | $1.2M | 214.1Kdirect | Sep 6, 2017 | Sep 7, 2017 | Form 4 ↗ |
| KING DAVID PPresident & CEO · Director | Sale | −37.2K | $156.77 | $5.8M | 221.6Kdirect | Sep 6, 2017 | Sep 7, 2017 | Form 4 ↗ |
| KING DAVID PPresident & CEO · Director | Sale | −132.7K | $157.06 | $20.8M | 214.1Kdirect | Sep 5, 2017 | Sep 7, 2017 | Form 4 ↗ |
| EBERTS F SAMUEL IIIChief Legal Officer, Secretary | Sale | −31.5K | $155.22 | $4.9M | 23.7Kdirect | Aug 25, 2017 | Aug 29, 2017 | Form 4 ↗ |
| Williams R SandersDirector | Sale | −11 | $156.92 | $2K | 6,973direct | Aug 11, 2017 | Aug 15, 2017 | Form 4 ↗ |
| Williams R SandersDirector | Sale | −8 | $156.91 | $1K | 6,984direct | Aug 11, 2017 | Aug 15, 2017 | Form 4 ↗ |
| Williams R SandersDirector | Sale | −2,881 | $156.90 | $452K | 6,992direct | Aug 11, 2017 | Aug 15, 2017 | Form 4 ↗ |
| Williams R SandersDirector | Sale | −200 | $156.68 | $31K | 9,873direct | Aug 11, 2017 | Aug 15, 2017 | Form 4 ↗ |
| Dodson Edward TPrincipal Accounting Officer | Sale | −2,671 | $160.13 | $428K | 5,031direct | Aug 1, 2017 | Aug 3, 2017 | Form 4 ↗ |
| Dodson Edward TPrincipal Accounting Officer | Sale | −200 | $160.13 | $32K | 7,702direct | Aug 1, 2017 | Aug 3, 2017 | Form 4 ↗ |
| Uthgenannt Lisa JChief Human Resources Officer | Sale | −5,000 | $160.00 | $800K | 3,622direct | Aug 1, 2017 | Aug 3, 2017 | Form 4 ↗ |
| EISENBERG GLENN AChief Financial Officer, EVP | Sale | −5,968 | $159.46 | $952K | 18.1Kdirect | Aug 1, 2017 | Aug 3, 2017 | Form 4 ↗ |
| BERBERIAN LANCESVP, Chief Information Officer | Sale | −3,613 | $139.84 | $505K | 5,789direct | May 22, 2017 | May 24, 2017 | Form 4 ↗ |
| BELINGARD JEAN-LUCDirector | Sale | −992 | $142.19 | $141K | 31.9Kdirect | May 9, 2017 | May 11, 2017 | Form 4 ↗ |
| EISENBERG GLENN AChief Financial Officer, EVP | Sale | −2,200 | $142.47 | $313K | 10.4Kdirect | Mar 9, 2017 | Mar 13, 2017 | Form 4 ↗ |
| EISENBERG GLENN AChief Financial Officer, EVP | Sale | −100 | $142.46 | $14K | 12.6Kdirect | Mar 9, 2017 | Mar 13, 2017 | Form 4 ↗ |
| MITTELSTAEDT ROBERT E JRDirector | Sale | −367 | $142.72 | $52K | 12.9Kdirect | Feb 24, 2017 | Feb 27, 2017 | Form 4 ↗ |
| MITTELSTAEDT ROBERT E JRDirector | Sale | −100 | $142.70 | $14K | 13.3Kdirect | Feb 24, 2017 | Feb 27, 2017 | Form 4 ↗ |
| MITTELSTAEDT ROBERT E JRDirector | Sale | −2,000 | $142.69 | $285K | 13.4Kdirect | Feb 24, 2017 | Feb 27, 2017 | Form 4 ↗ |
| MITTELSTAEDT ROBERT E JRDirector | Sale | −2,633 | $142.69 | $376K | 15.4Kdirect | Feb 24, 2017 | Feb 27, 2017 | Form 4 ↗ |
| MITTELSTAEDT ROBERT E JRDirector | Sale | −200 | $142.68 | $29K | 18.0Kdirect | Feb 24, 2017 | Feb 27, 2017 | Form 4 ↗ |
| ANDERSON KERRII BDirector | Sale | −1,000 | $140.00 | $140K | 15.8Kdirect | Feb 23, 2017 | Feb 27, 2017 | Form 4 ↗ |
| ANDERSON KERRII BDirector | Sale | −992 | $140.00 | $139K | 15.8Kdirect | Feb 23, 2017 | Feb 27, 2017 | Form 4 ↗ |
| Uthgenannt Lisa JChief Human Resources Officer | Sale | −1,177 | $140.00 | $165K | 3,660direct | Aug 9, 2016 | Aug 11, 2016 | Form 4 ↗ |
| EISENBERG GLENN AChief Financial Officer, EVP | Sale | −400 | $140.68 | $56K | 8,268direct | Aug 4, 2016 | Aug 8, 2016 | Form 4 ↗ |
| EISENBERG GLENN AChief Financial Officer, EVP | Sale | −7,600 | $140.07 | $1.1M | 8,668direct | Aug 4, 2016 | Aug 8, 2016 | Form 4 ↗ |
| MITTELSTAEDT ROBERT E JRDirector | Sale | −992 | $140.15 | $139K | 11.3Kdirect | Aug 4, 2016 | Aug 8, 2016 | Form 4 ↗ |
| KING DAVID PPresident & CEO · Director | Sale | −72.6K | $127.65 | $9.3M | 147.4Kdirect | Jun 13, 2016 | Jun 15, 2016 | Form 4 ↗ |
| KING DAVID PPresident & CEO · Director | Sale | −4,500 | $129.47 | $583K | 147.4Kdirect | Jun 13, 2016 | Jun 15, 2016 | Form 4 ↗ |
| KING DAVID PPresident & CEO · Director | Sale | −45.9K | $128.79 | $5.9M | 151.9Kdirect | Jun 13, 2016 | Jun 15, 2016 | Form 4 ↗ |
| KING DAVID PPresident & CEO · Director | Sale | −73.5K | $127.76 | $9.4M | 197.8Kdirect | Jun 13, 2016 | Jun 15, 2016 | Form 4 ↗ |
| Uthgenannt Lisa JChief Human Resources Officer | Sale | −3,740 | $125.17 | $468K | 4,837direct | Apr 29, 2016 | May 13, 2016 | Form 4 ↗ |
| Dodson Edward TPrincipal Accounting Officer | Sale | −9,392 | $126.42 | $1.2M | 2,717direct | Apr 27, 2016 | Apr 29, 2016 | Form 4 ↗ |
| EBERTS F SAMUEL IIIChief Legal Officer, Secretary | Sale | −4,219 | $116.85 | $493K | 18.1Kdirect | Mar 31, 2016 | Apr 1, 2016 | Form 4 ↗ |
| Boyle James T. Jr.EVP,CEO of LabCorp Diagnostics | Sale | −4,941 | $117.19 | $579K | 23.5Kdirect | Mar 31, 2016 | Apr 1, 2016 | Form 4 ↗ |
| Boyle James T. Jr.EVP,CEO of LabCorp Diagnostics | Sale | −13.2K | $116.67 | $1.5M | 28.4Kdirect | Mar 31, 2016 | Apr 1, 2016 | Form 4 ↗ |
| EBERTS F SAMUEL IIIChief Legal Officer, Secretary | Sale | −309 | $115.32 | $36K | 18.1Kdirect | Mar 14, 2016 | Mar 15, 2016 | Form 4 ↗ |
| Boyle James T. Jr.EVP,CEO of LabCorp Diagnostics | Sale | −1,543 | $115.32 | $178K | 23.5Kdirect | Mar 14, 2016 | Mar 15, 2016 | Form 4 ↗ |
| BELINGARD JEAN-LUCDirector | Sale | −1,078 | $109.75 | $118K | 29.4Kdirect | Feb 25, 2016 | Feb 29, 2016 | Form 4 ↗ |
| BELINGARD JEAN-LUCDirector | Sale | −218 | $109.70 | $24K | 30.5Kdirect | Feb 25, 2016 | Feb 29, 2016 | Form 4 ↗ |
| Boyle James T. Jr.EVP,CEO of LabCorp Diagnostics | Sale | −2,160 | $103.02 | $223K | 23.5Kdirect | Feb 16, 2016 | Feb 18, 2016 | Form 4 ↗ |
| Boyle James T. Jr.EVP,CEO of LabCorp Diagnostics | Sale | −1,895 | $103.02 | $195K | 25.6Kdirect | Feb 16, 2016 | Feb 18, 2016 | Form 4 ↗ |
| EBERTS F SAMUEL IIIChief Legal Officer, Secretary | Sale | −370 | $103.02 | $38K | 18.1Kdirect | Feb 16, 2016 | Feb 18, 2016 | Form 4 ↗ |
| Boyle James T. Jr.EVP,CEO of LabCorp Diagnostics | Sale | −2,712 | $101.67 | $276K | 23.5Kdirect | Feb 12, 2016 | Feb 16, 2016 | Form 4 ↗ |
| EBERTS F SAMUEL IIIChief Legal Officer, Secretary | Sale | −405 | $101.67 | $41K | 18.1Kdirect | Feb 12, 2016 | Feb 16, 2016 | Form 4 ↗ |
| EBERTS F SAMUEL IIIChief Legal Officer, Secretary | Sale | −1,215 | $119.05 | $145K | 18.1Kdirect | Jan 8, 2016 | Jan 12, 2016 | Form 4 ↗ |
| EBERTS F SAMUEL IIIChief Legal Officer, Secretary | Sale | −1,010 | $123.31 | $125K | 19.3Kdirect | Dec 8, 2015 | Dec 10, 2015 | Form 4 ↗ |
| Williams R SandersDirector | Sale | −400 | $124.33 | $50K | 4,176direct | Nov 2, 2015 | Nov 4, 2015 | Form 4 ↗ |
| Williams R SandersDirector | Sale | −200 | $124.31 | $25K | 4,576direct | Nov 2, 2015 | Nov 4, 2015 | Form 4 ↗ |
| Williams R SandersDirector | Sale | −100 | $124.30 | $12K | 4,776direct | Nov 2, 2015 | Nov 4, 2015 | Form 4 ↗ |
| Williams R SandersDirector | Sale | −200 | $124.29 | $25K | 4,876direct | Nov 2, 2015 | Nov 4, 2015 | Form 4 ↗ |
| Williams R SandersDirector | Sale | −950 | $124.28 | $118K | 5,076direct | Nov 2, 2015 | Nov 4, 2015 | Form 4 ↗ |
| KING DAVID PPresident & CEO · Director | Sale | −16.3K | $128.43 | $2.1M | 81.2Kdirect | Aug 3, 2015 | Aug 5, 2015 | Form 4 ↗ |
| KING DAVID PPresident & CEO · Director | Sale | −33.7K | $127.68 | $4.3M | 97.5Kdirect | Aug 3, 2015 | Aug 5, 2015 | Form 4 ↗ |
| KING DAVID PPresident & CEO · Director | Sale | −29.5K | $122.04 | $3.6M | 66.1Kdirect | Jul 1, 2015 | Jul 6, 2015 | Form 4 ↗ |
| KING DAVID PPresident & CEO · Director | Sale | −20.5K | $121.41 | $2.5M | 95.6Kdirect | Jul 1, 2015 | Jul 6, 2015 | Form 4 ↗ |
| KING DAVID PPresident & CEO · Director | Sale | −49.1K | $118.59 | $5.8M | 65.9Kdirect | Jun 1, 2015 | Jun 3, 2015 | Form 4 ↗ |
| KING DAVID PPresident & CEO · Director | Sale | −909 | $117.87 | $107K | 115.0Kdirect | Jun 1, 2015 | Jun 3, 2015 | Form 4 ↗ |
| MITTELSTAEDT ROBERT E JRDirector | Sale | −796 | $119.03 | $95K | 10.1Kdirect | May 19, 2015 | May 21, 2015 | Form 4 ↗ |
| MITTELSTAEDT ROBERT E JRDirector | Sale | −100 | $119.02 | $12K | 10.9Kdirect | May 19, 2015 | May 21, 2015 | Form 4 ↗ |
| MITTELSTAEDT ROBERT E JRDirector | Sale | −400 | $119.01 | $48K | 11.0Kdirect | May 19, 2015 | May 21, 2015 | Form 4 ↗ |
| Williams R SandersDirector | Sale | −102 | $118.10 | $12K | 4,176direct | May 11, 2015 | May 14, 2015 | Form 4 ↗ |
| Williams R SandersDirector | Sale | −100 | $118.08 | $12K | 4,278direct | May 11, 2015 | May 14, 2015 | Form 4 ↗ |
| Williams R SandersDirector | Sale | −200 | $118.06 | $24K | 4,378direct | May 11, 2015 | May 14, 2015 | Form 4 ↗ |
| Williams R SandersDirector | Sale | −100 | $118.05 | $12K | 4,578direct | May 11, 2015 | May 14, 2015 | Form 4 ↗ |
| Williams R SandersDirector | Sale | −463 | $118.02 | $55K | 4,678direct | May 11, 2015 | May 14, 2015 | Form 4 ↗ |
| BELINGARD JEAN-LUCDirector | Sale | −1,542 | $123.10 | $190K | 29.4Kdirect | Apr 29, 2015 | May 1, 2015 | Form 4 ↗ |
| Boyle James T. Jr.EVP,CEO of LabCorp Diagnostics | Sale | −1,194 | $126.56 | $151K | 23.5Kdirect | Apr 23, 2015 | Apr 27, 2015 | Form 4 ↗ |
| Boyle James T. Jr.EVP,CEO of LabCorp Diagnostics | Sale | −200 | $126.56 | $25K | 24.6Kdirect | Apr 23, 2015 | Apr 27, 2015 | Form 4 ↗ |
| Brecher Mark ECMO, LabCorp Diagnostics | Sale | −347 | $127.00 | $44K | 5,511direct | Mar 31, 2015 | Apr 1, 2015 | Form 4 ↗ |
| Brecher Mark ECMO, LabCorp Diagnostics | Sale | −20.3K | $126.98 | $2.6M | 5,858direct | Mar 30, 2015 | Apr 1, 2015 | Form 4 ↗ |
| Boyle James T. Jr.EVP, Chief Operating Officer | Sale | −100 | $123.79 | $12K | 23.5Kdirect | Mar 3, 2015 | Mar 4, 2015 | Form 4 ↗ |
| Boyle James T. Jr.EVP, Chief Operating Officer | Sale | −100 | $123.78 | $12K | 23.6Kdirect | Mar 3, 2015 | Mar 4, 2015 | Form 4 ↗ |
| Boyle James T. Jr.EVP, Chief Operating Officer | Sale | −200 | $123.71 | $25K | 23.7Kdirect | Mar 3, 2015 | Mar 4, 2015 | Form 4 ↗ |
| Boyle James T. Jr.EVP, Chief Operating Officer | Sale | −100 | $123.69 | $12K | 23.9Kdirect | Mar 3, 2015 | Mar 4, 2015 | Form 4 ↗ |
| Boyle James T. Jr.EVP, Chief Operating Officer | Sale | −500 | $123.68 | $62K | 24.0Kdirect | Mar 3, 2015 | Mar 4, 2015 | Form 4 ↗ |
| Boyle James T. Jr.EVP, Chief Operating Officer | Sale | −200 | $123.67 | $25K | 24.5Kdirect | Mar 3, 2015 | Mar 4, 2015 | Form 4 ↗ |
| Boyle James T. Jr.EVP, Chief Operating Officer | Sale | −37 | $123.61 | $5K | 24.7Kdirect | Mar 3, 2015 | Mar 4, 2015 | Form 4 ↗ |
| Williams R SandersDirector | Sale | −1,300 | $123.97 | $161K | 5,141direct | Feb 26, 2015 | Mar 2, 2015 | Form 4 ↗ |
| Williams R SandersDirector | Sale | −967 | $123.96 | $120K | 6,441direct | Feb 26, 2015 | Mar 2, 2015 | Form 4 ↗ |
| HERRING JOSEPH LCEO of Covance Drug Division | Sale | −6,158 | $122.03 | $751K | 0direct | Feb 25, 2015 | Feb 27, 2015 | Form 4 ↗ |
| HERRING JOSEPH LCEO of Covance Drug Division | Sale | −30.7K | $121.56 | $3.7M | 6,158direct | Feb 25, 2015 | Feb 27, 2015 | Form 4 ↗ |
| Boyle James T. Jr.EVP, Chief Operating Officer | Sale | −1,986 | $116.66 | $232K | 25.8Kdirect | Feb 13, 2015 | Feb 17, 2015 | Form 4 ↗ |
| Boyle James T. Jr.EVP, Chief Operating Officer | Sale | −1,897 | $116.66 | $221K | 27.8Kdirect | Feb 13, 2015 | Feb 17, 2015 | Form 4 ↗ |
| Boyle James T. Jr.EVP, Chief Operating Officer | Sale | −2,714 | $116.71 | $317K | 25.8Kdirect | Feb 12, 2015 | Feb 17, 2015 | Form 4 ↗ |
| KING DAVID PPresident & CEO · Director | Sale | −4,700 | $105.58 | $496K | 55.6Kdirect | Sep 22, 2014 | Sep 24, 2014 | Form 4 ↗ |
| KING DAVID PPresident & CEO · Director | Sale | −60.5K | $104.64 | $6.3M | 60.3Kdirect | Sep 22, 2014 | Sep 24, 2014 | Form 4 ↗ |
| Williams R SandersDirector | Sale | −600 | $107.96 | $65K | 5,905direct | Sep 5, 2014 | Sep 9, 2014 | Form 4 ↗ |
| Williams R SandersDirector | Sale | −1,400 | $107.95 | $151K | 6,505direct | Sep 5, 2014 | Sep 9, 2014 | Form 4 ↗ |
| KING DAVID PPresident & CEO · Director | Sale | −65.2K | $106.10 | $6.9M | 55.6Kdirect | Aug 22, 2014 | Aug 26, 2014 | Form 4 ↗ |
| KING DAVID PPresident & CEO · Director | Sale | −1,600 | $105.99 | $170K | 55.6Kdirect | Jul 22, 2014 | Jul 24, 2014 | Form 4 ↗ |
| KING DAVID PPresident & CEO · Director | Sale | −63.6K | $105.54 | $6.7M | 57.2Kdirect | Jul 22, 2014 | Jul 24, 2014 | Form 4 ↗ |
| Boyle James T. Jr.EVP, Chief Operating Officer | Sale | −38.6K | $103.00 | $4.0M | 25.8Kdirect | Jun 9, 2014 | Jun 10, 2014 | Form 4 ↗ |
| Hayes William BChief Financial Officer, EVP | Sale | −22.1K | $104.50 | $2.3M | 19.4Kdirect | Jun 6, 2014 | Jun 10, 2014 | Form 4 ↗ |
| Hayes William BChief Financial Officer, EVP | Sale | −25.3K | $103.99 | $2.6M | 41.5Kdirect | Jun 6, 2014 | Jun 10, 2014 | Form 4 ↗ |
| EBERTS F SAMUEL IIIChief Legal Officer, Secretary | Sale | −10.0K | $104.37 | $1.0M | 19.3Kdirect | Jun 6, 2014 | Jun 10, 2014 | Form 4 ↗ |
| Brecher Mark EChief Medical Officer | Sale | −2,600 | $102.31 | $266K | 5,754direct | Jun 4, 2014 | Jun 6, 2014 | Form 4 ↗ |
| WEIKEL M KEITHDirector | Sale | −883 | $98.28 | $87K | 12.4Kdirect | May 7, 2014 | May 9, 2014 | Form 4 ↗ |
| WEIKEL M KEITHDirector | Sale | −1,101 | $98.27 | $108K | 13.2Kdirect | May 7, 2014 | May 9, 2014 | Form 4 ↗ |
| BELINGARD JEAN-LUCDirector | Sale | −100 | $98.68 | $10K | 26.6Kdirect | Apr 30, 2014 | May 2, 2014 | Form 4 ↗ |
| BELINGARD JEAN-LUCDirector | Sale | −1,784 | $98.68 | $176K | 26.7Kdirect | Apr 30, 2014 | May 2, 2014 | Form 4 ↗ |
| BELINGARD JEAN-LUCDirector | Sale | −100 | $98.68 | $10K | 28.5Kdirect | Apr 30, 2014 | May 2, 2014 | Form 4 ↗ |
| Hayes William BChief Financial Officer, EVP | Sale | −2,497 | $98.39 | $246K | 19.4Kdirect | Apr 30, 2014 | May 2, 2014 | Form 4 ↗ |
| LANE WENDY EDirector | Sale | −390 | $98.97 | $39K | 17.4Kdirect | Apr 30, 2014 | May 2, 2014 | Form 4 ↗ |
| MITTELSTAEDT ROBERT E JRDirector | Sale | −1,542 | $98.39 | $152K | 7,015direct | Apr 30, 2014 | May 2, 2014 | Form 4 ↗ |
| MITTELSTAEDT ROBERT E JRDirector | Sale | −1,984 | $98.39 | $195K | 7,015direct | Apr 30, 2014 | May 2, 2014 | Form 4 ↗ |
Source: SEC EDGAR Form 4 and Form 5 filings, SEC's quarterly bulk dataset through Jun 30, 2026, and KeyVex's half-hourly read of new filings since. Every row links its filing. Amendments are marked. Nothing here is a recommendation. All insider activity, market-wide →